DEERFIELD – Baxter International Thursday reported net income of $552 million and earnings per diluted share of $1, compared to net income of $588 million and earnings per diluted share of $1.04 in the same period last year.
First-quarter 2013 results include after-tax special items totaling $29 million (or $0.05 per diluted share) primarily for deal-related costs associated with Baxter’s planned acquisition of Gambro AB, a global medical technology company.
Worldwide sales of $3.45 billion increased 2 percent compared to $3.39 billion reported in the first quarter of 2012. Sales within the U.S. increased 1 percent, totaling $1.48 billion, while international sales of $1.97 billion increased 2 percent. The impact of foreign currency on sales growth in the quarter was immaterial.